Other News

FEops Announces 2.000 Patients Modelled With FEops HEARTguide™

GENT, Belgium–(BUSINESS WIRE)–FEops, a digital health leader in personalized predictive planning for structural heart interventions, is proud to announce having modeled 2000 patients with FEops HEARTguide™ for the pre-operative planning of structural heart interventions. FEops HEARTguide™ is currently commercially available in the European Union, Canada and Australia for its TAVI […]

Veteran Cardiology Medtech Executive Tim O’Malley Joins iMedrix Mobile Cardiology as CEO

KardioScreen-Intelligent Medical Metrics in Cardiology allowing for medical grade diagnostics while in a Mobile environment MILPITAS, Calif., Jan. 29, 2021 /PRNewswire/ — Tim O’Malley, has joined iMedrix Inc. manufacturer of KardioScreen, the world’s first medical-grade mobile cardiac monitoring device, as its new Chief Executive Officer.  Mr. O’Malley joins the firm from EarlySense Inc., where he was […]

Medtronic Receives FDA Approval of DiamondTemp Ablation System for the Treatment of Patients with Atrial Fibrillation

Clinical Trial Demonstrates Procedural Efficiencies, Safety, Effectiveness and Non-Inferiority of DiamondTemp System DUBLIN, Jan. 29, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of the DiamondTemp™ Ablation (DTA) system which treats patients with recurrent, symptomatic paroxysmal atrial […]

CathVision clinical results to be presented at the AF Symposium

COPENHAGEN, Denmark, Jan. 29, 2021 /PRNewswire/ — CathVision ApS, a medical device company developing a novel cardiac electrophysiology system and artificial intelligence platform to guide ablation therapy for heart rhythm disorders, is featured at the 26th annual international AF Symposium, held online January 29-31st. On January 30th, Professor Josef Kautzner, Institute of Cardiology and Experimental Medicine […]

FARAPULSE Receives European Approval To Commercialize Its Leading Pulsed Field Ablation System To Treat Paroxysmal Atrial Fibrillation

– FARAPULSE becomes first company in the world to commercialize a cardiac PFA system – MENLO PARK, Calif., Jan. 29, 2021 /PRNewswire/ – FARAPULSE Inc. (“FARAPULSE” or “the Company”) today announced that it has received the Conformité Européene (CE) Mark for its FARAPULSE Pulsed Field Ablation (PFA) system for the treatment of […]

Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical

ENGLEWOOD, Colo., Jan. 28, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced that it has promoted Anna Lucsok to Chief Operating Officer (COO) of Zynex Medical, its pain management division. Joseph Papandrea previously held […]

Spectrum Dynamics Medical Lawsuit Against GE Allowed to Continue; Jury Trial May Proceed

Judge denies both attempts by GE requesting dismissal of technology misappropriation lawsuit filed by Spectrum Dynamics regarding its VERITON® digital scanner unique technology SARASOTA, Fla., Jan. 29, 2021 /PRNewswire/ — Spectrum Dynamics Medical, a global leader, developer, manufacturer and seller of digital SPECT imaging equipment, announced that its lawsuit against GE for trade secret […]

JanOne Prices $6.0 Million Common Stock Offering

LAS VEGAS, Jan. 29, 2021 /PRNewswire/ — JanOne Inc. (NASDAQ: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 571,428 shares of its common stock at a […]

Micro Interventional Devices, Inc. ™ announces the submission of technical documentation for CE Marking for the MIA-T ™ Percutaneous Tricuspid Annuloplasty System

The application includes data from the STTAR clinical study with a one-year follow-up period. NEWTOWN, Pa. Jan. 29, 2021 / PRNewswire / –  Micro Interventional Devices, Inc. ™  (MID) announced today that it has provided the technical documentation required for CE approval of its MIA-T ™ Percutaneous Tricuspid Annuloplasty System for tricuspid valve […]

Mesoblast Operational and Financial Highlights for Quarter Ended December 31, 2020

NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on its pipeline of late-stage product candidates, and an activity report for the second quarter ended December 31, 2020. Mesoblast Chief Executive Dr Silviu Itescu […]